Revenue | ₹212.88Cr |
Net Profits | ₹-12.61Cr |
Net Profit Margins | -5.92% |
Orchid Pharma Ltd’s revenue fell -5.73% since last year same period to ₹212.88Cr in the Q3 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated 4.2% jump in its revenue since last 3-months.
Orchid Pharma Ltd’s net profit fell -160.68% since last year same period to ₹-12.61Cr in the Q3 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated -120.45% fall in its net profits since last 3-months.
Orchid Pharma Ltd’s net profit margin fell -164.37% since last year same period to -5.92% in the Q3 2025-2026. On a quarterly growth basis, Orchid Pharma Ltd has generated -111.57% fall in its net profit margins since last 3-months.
The revenue for Orchid Pharma Ltd in the Q3 results 2025 was ₹212.88Cr.
The net profit for Orchid Pharma Ltd in the Q3 results 2025 was ₹-12.61Cr.
The net profit margin for Orchid Pharma Ltd in the Q3 results 2025 was -5.92%.
The revenue for Orchid Pharma Ltd in the Q3 results 2024 was ₹225.83Cr.
The net profit for Orchid Pharma Ltd in the Q3 results 2024 was ₹20.78Cr.
The net profit margin for Orchid Pharma Ltd in the Q3 results 2024 was 9.20%.